NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|255683531|ref|NP_001157499|]
View 

puromycin-sensitive aminopeptidase [Danio rerio]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
17-454 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 708.19  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  17 VNYGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVPDGGEEINATGFNYQNEDEKVTLCFPSTLQKG 96
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  97 S-GSLKIDFVGELNDKMKGFYRSKY-SSSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNVV 174
Cdd:cd09601   81 EnYTLSIEFTGKLNDDLRGFYRSSYtDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 175 DRKPYAEDqsLVEVKFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVP 254
Cdd:cd09601  161 ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 255 YPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFAS 334
Cdd:cd09601  239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 335 WIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDEDFRK 414
Cdd:cd09601  319 YMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|....
gi 255683531 415 GMNAYLLKFQHKNASTEDLWECLEQASG----KPIAAVMNSWTK 454
Cdd:cd09601  399 GLRKYLKKHAYGNATTDDLWEALQEASGeskpLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
533-846 1.97e-107

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 333.47  E-value: 1.97e-107
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  533 WIKINPGTVGFYRIQYSSAMLESLLPGIRDLTLLPVDRLGLQNDLFSLARAGMISTVEVLKVMEAFVNEPNYTVWSDLSC 612
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  613 NLGVLSSLLSHTDFHEDIQEFIRDLFTPIGMKLGWDSRTGEGHLDALLRGLVLGKLGKAGHKATLEEARRRFREHVEGKQ 692
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  693 ILSADLRSPVYLTVLKHGDSTTLDTMLKLHKQADMQEEKNRIERVLGAIPAPDLIQRVLNFAL-SEEVRPQDTVSVIGGV 771
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 255683531  772 AgSSKQGRKAAWKFVKDNWEELHNRYQGGFLISRLIKLTVDGFAIDKMAAEVKSFFESHHAPAAERTVQQCCENI 846
Cdd:pfam11838 241 A-SNPAGRDLAWDFVKENWDALVKRLGGGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLRRALAQALETI 314
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
17-454 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 708.19  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  17 VNYGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVPDGGEEINATGFNYQNEDEKVTLCFPSTLQKG 96
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  97 S-GSLKIDFVGELNDKMKGFYRSKY-SSSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNVV 174
Cdd:cd09601   81 EnYTLSIEFTGKLNDDLRGFYRSSYtDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 175 DRKPYAEDqsLVEVKFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVP 254
Cdd:cd09601  161 ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 255 YPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFAS 334
Cdd:cd09601  239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 335 WIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDEDFRK 414
Cdd:cd09601  319 YMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|....
gi 255683531 415 GMNAYLLKFQHKNASTEDLWECLEQASG----KPIAAVMNSWTK 454
Cdd:cd09601  399 GLRKYLKKHAYGNATTDDLWEALQEASGeskpLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
9-615 3.29e-149

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 452.95  E-value: 3.29e-149
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   9 RLPTDVYPVNYGLRLKPDLVDFTFEGKLEAAVEVTQ-GTNQIVMNCADIDIITASfvpdggeeINATGFNYQNEDEKVTL 87
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEaPLDSLVLDLKGLEVTSVT--------VDGKPLDFTRDGERLTI 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  88 CFPSTLQKG-SGSLKIDFVGELNDKMKGFYRSKYSSSGEVryAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRV 166
Cdd:COG0308   82 TLPKPLAPGeTFTLEIEYSGKPSNGGEGLYRSGDPPDGPP--YLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAGWV 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 167 ALSNMNVVDRKPYAEDQSLVEvkFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPF 246
Cdd:COG0308  160 AVSNGNLVSETELGDGRTTWH--WADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 247 YKDYFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETalLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHL 326
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK--VLADETATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 327 WLNEGFASWIEYLCVDHCFPEyDIWTQ-FVSADYTRALDLDALDNSHPIEVDvgHPSEVDEIFDAISYSKGASVIRMLHN 405
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYGK-DAADRiFVGALRSYAFAEDAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHMLRT 392
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 406 YIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSWTKQMGFPIIVVDQEQHGSDRV-LKISQKKFcas 484
Cdd:COG0308  393 LLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKVtLTLRQTPP--- 469
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 485 gprndeDCPNWMVPISIcTSEDPSCTKTKILLDQPETTVnitNVAPDhWIKInpgtvgfyrIQYSSAmLESLLPGIRDlt 564
Cdd:COG0308  470 ------RPHPFHIPLEV-GLLGGKLTARTVLLDGEQTEL---VAKPD-PVLL---------LRLDDE-LAFLLAHDSD-- 526
                        570       580       590       600       610
                 ....*....|....*....|....*....|....*....|....*....|.
gi 255683531 565 llPVDRLGLQNDLFSLARAGMISTVEVLKvmeafvnEPNYTVWSDLSCNLG 615
Cdd:COG0308  527 --PFNRWEALQALWRDGEADYLDALRALA-------DTDPAVRAEALALLG 568
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
235-452 1.65e-122

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 368.92  E-value: 1.65e-122
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  235 FALEVATKTLPFYKDYFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWF 314
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  315 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYS 394
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 255683531  395 KGASVIRMLHNYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASG-KPIAAVMNSW 452
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
533-846 1.97e-107

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 333.47  E-value: 1.97e-107
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  533 WIKINPGTVGFYRIQYSSAMLESLLPGIRDLTLLPVDRLGLQNDLFSLARAGMISTVEVLKVMEAFVNEPNYTVWSDLSC 612
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  613 NLGVLSSLLSHTDFHEDIQEFIRDLFTPIGMKLGWDSRTGEGHLDALLRGLVLGKLGKAGHKATLEEARRRFREHVEGKQ 692
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  693 ILSADLRSPVYLTVLKHGDSTTLDTMLKLHKQADMQEEKNRIERVLGAIPAPDLIQRVLNFAL-SEEVRPQDTVSVIGGV 771
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 255683531  772 AgSSKQGRKAAWKFVKDNWEELHNRYQGGFLISRLIKLTVDGFAIDKMAAEVKSFFESHHAPAAERTVQQCCENI 846
Cdd:pfam11838 241 A-SNPAGRDLAWDFVKENWDALVKRLGGGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLRRALAQALETI 314
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
92-490 9.46e-81

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 277.83  E-value: 9.46e-81
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   92 TLQKGSGSLKIDFVGELNDKMKGFYRSKYSSSGEVrYAaVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNM 171
Cdd:TIGR02412  84 GLLTGENTLRVEATRAYTNTGEGLHRFVDPVDGEV-YL-YTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNS 161
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  172 nvVDRKPYAEDQSLVEvKFATTPIMSTYLVAFVIGEYDFVEsQSSDGVTVRVYTPVGKAEQ--GKFALEVATKTLPFYKD 249
Cdd:TIGR02412 162 --RETDVTPEPADRRW-EFPETPKLSTYLTAVAAGPYHSVQ-DESRSYPLGIYARRSLAQYldADAIFTITRQGLAFFHR 237
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  250 YFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNscASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLN 329
Cdd:TIGR02412 238 KFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEAT--RAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLN 315
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  330 EGFASWIEYLCVDHCfPEY-DIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIG 408
Cdd:TIGR02412 316 ESFAEYMGTLASAEA-TEYtDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVG 394
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  409 DEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSWTKQMGFPIIVVDQEqhgsdrvlkISQKKFCASGPRN 488
Cdd:TIGR02412 395 EEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEIT---------TDGGVVSALYPES 465

                  ..
gi 255683531  489 DE 490
Cdd:TIGR02412 466 SG 467
pepN PRK14015
aminopeptidase N; Provisional
120-529 1.63e-22

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 103.67  E-value: 1.63e-22
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 120 YSSSGevryAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDR--VALSNMNVVDRKPYAEDQslvevKFAT----T 193
Cdd:PRK14015 115 YRSGG----MFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKypVLLSNGNLVESGELPDGR-----HWATwedpF 185
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 194 PIMStYLVAFVIGEYDFVE----SQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVPYplpkiDL-----IA 264
Cdd:PRK14015 186 PKPS-YLFALVAGDLDVLEdtftTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY-----DLdifmiVA 259
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 265 IADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGfaswieyLCV--D 342
Cdd:PRK14015 260 VDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEG-------LTVfrD 332
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 343 HCFpeydiwtqfvSADYT-RAL----DLDALDN----------SHPIEvdvghPSEVDEI---FDAISYSKGASVIRMLH 404
Cdd:PRK14015 333 QEF----------SADLGsRAVkrieDVRVLRAaqfaedagpmAHPVR-----PDSYIEInnfYTATVYEKGAEVIRMLH 397
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 405 NYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNsWTKQMGFPIIVVDQEQHGSDRVLKISQKKFCAS 484
Cdd:PRK14015 398 TLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFRR-WYSQAGTPRVTVSDEYDAAAGTYTLTLSQSTPP 476
                        410       420       430       440       450
                 ....*....|....*....|....*....|....*....|....*....|....*
gi 255683531 485 GPRNDEDCPnWMVPISI----------CTSEDPSCTKTKILLDQPETTVNITNVA 529
Cdd:PRK14015 477 TPGQPEKQP-LHIPVAIglldpdgkelPLQLEGEPVERVLELTEAEQTFTFENVA 530
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
17-454 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 708.19  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  17 VNYGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVPDGGEEINATGFNYQNEDEKVTLCFPSTLQKG 96
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  97 S-GSLKIDFVGELNDKMKGFYRSKY-SSSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNVV 174
Cdd:cd09601   81 EnYTLSIEFTGKLNDDLRGFYRSSYtDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 175 DRKPYAEDqsLVEVKFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVP 254
Cdd:cd09601  161 ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 255 YPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFAS 334
Cdd:cd09601  239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 335 WIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDEDFRK 414
Cdd:cd09601  319 YMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|....
gi 255683531 415 GMNAYLLKFQHKNASTEDLWECLEQASG----KPIAAVMNSWTK 454
Cdd:cd09601  399 GLRKYLKKHAYGNATTDDLWEALQEASGeskpLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
9-615 3.29e-149

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 452.95  E-value: 3.29e-149
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   9 RLPTDVYPVNYGLRLKPDLVDFTFEGKLEAAVEVTQ-GTNQIVMNCADIDIITASfvpdggeeINATGFNYQNEDEKVTL 87
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEaPLDSLVLDLKGLEVTSVT--------VDGKPLDFTRDGERLTI 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  88 CFPSTLQKG-SGSLKIDFVGELNDKMKGFYRSKYSSSGEVryAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRV 166
Cdd:COG0308   82 TLPKPLAPGeTFTLEIEYSGKPSNGGEGLYRSGDPPDGPP--YLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAGWV 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 167 ALSNMNVVDRKPYAEDQSLVEvkFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPF 246
Cdd:COG0308  160 AVSNGNLVSETELGDGRTTWH--WADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 247 YKDYFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETalLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHL 326
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK--VLADETATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 327 WLNEGFASWIEYLCVDHCFPEyDIWTQ-FVSADYTRALDLDALDNSHPIEVDvgHPSEVDEIFDAISYSKGASVIRMLHN 405
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYGK-DAADRiFVGALRSYAFAEDAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHMLRT 392
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 406 YIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSWTKQMGFPIIVVDQEQHGSDRV-LKISQKKFcas 484
Cdd:COG0308  393 LLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKVtLTLRQTPP--- 469
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 485 gprndeDCPNWMVPISIcTSEDPSCTKTKILLDQPETTVnitNVAPDhWIKInpgtvgfyrIQYSSAmLESLLPGIRDlt 564
Cdd:COG0308  470 ------RPHPFHIPLEV-GLLGGKLTARTVLLDGEQTEL---VAKPD-PVLL---------LRLDDE-LAFLLAHDSD-- 526
                        570       580       590       600       610
                 ....*....|....*....|....*....|....*....|....*....|.
gi 255683531 565 llPVDRLGLQNDLFSLARAGMISTVEVLKvmeafvnEPNYTVWSDLSCNLG 615
Cdd:COG0308  527 --PFNRWEALQALWRDGEADYLDALRALA-------DTDPAVRAEALALLG 568
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
235-452 1.65e-122

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 368.92  E-value: 1.65e-122
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  235 FALEVATKTLPFYKDYFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWF 314
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  315 GNLVTMEWWTHLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYS 394
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 255683531  395 KGASVIRMLHNYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASG-KPIAAVMNSW 452
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
31-455 1.86e-113

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 353.74  E-value: 1.86e-113
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  31 TFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVpdgGEEINATGFNyqneDEKVTLcfPSTLQKGSGSLKIDFvgelnd 110
Cdd:cd09602   30 TFRGTVTIRFTLREPGASLFLDFRGGEVKSVTLN---GRPLDPSAFD----GERITL--PGLLKAGENTVVVEF------ 94
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 111 kmkgfyRSKYSSSGE--VRY-----AAV---TQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNVVDRkpyA 180
Cdd:cd09602   95 ------TAPYSSDGEglHRFvdpadGETylyTLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTVISNGPETST---E 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 181 EDQSLVEVKFATTPIMSTYLVAFVIGEYDFVESQSsDGVTVRVYTPVGKAEQGKFA---LEVATKTLPFYKDYFSVPYPL 257
Cdd:cd09602  166 EAGGRKRWRFAETPPLSTYLFAFVAGPYHRVEDEH-DGIPLGLYCRESLAEYERDAdeiFEVTKQGLDFYEDYFGIPYPF 244
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 258 PKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNscASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFASWIE 337
Cdd:cd09602  245 GKYDQVFVPEFNFGAMENPGAVTFRESYLFREEPT--RAQRLRRANTILHEMAHMWFGDLVTMKWWDDLWLNESFADFMA 322
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 338 YLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDEDFRKGMN 417
Cdd:cd09602  323 AKALAEATPFTDAWLTFLLRRKPWAYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKGASVLKQLVALVGEEAFRAGLR 402
                        410       420       430
                 ....*....|....*....|....*....|....*...
gi 255683531 418 AYLLKFQHKNASTEDLWECLEQASGKPIAAvmnsWTKQ 455
Cdd:cd09602  403 EYFKKHAYGNATLDDLIAALDEASGRDLSA----WADA 436
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
533-846 1.97e-107

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 333.47  E-value: 1.97e-107
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  533 WIKINPGTVGFYRIQYSSAMLESLLPGIRDLTLLPVDRLGLQNDLFSLARAGMISTVEVLKVMEAFVNEPNYTVWSDLSC 612
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLLSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAALS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  613 NLGVLSSLLSHTDFHEDIQEFIRDLFTPIGMKLGWDSRTGEGHLDALLRGLVLGKLGKAGHKATLEEARRRFREHVEGKQ 692
Cdd:pfam11838  81 QLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLDGDD 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  693 ILSADLRSPVYLTVLKHGDSTTLDTMLKLHKQADMQEEKNRIERVLGAIPAPDLIQRVLNFAL-SEEVRPQDTVSVIGGV 771
Cdd:pfam11838 161 AIPPDLRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALdSDEVRNQDLRAVIAGL 240
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 255683531  772 AgSSKQGRKAAWKFVKDNWEELHNRYQGGFLISRLIKLTVDGFAIDKMAAEVKSFFESHHAPAAERTVQQCCENI 846
Cdd:pfam11838 241 A-SNPAGRDLAWDFVKENWDALVKRLGGGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLRRALAQALETI 314
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
19-439 2.23e-103

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 326.32  E-value: 2.23e-103
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  19 YGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVPDGGEeinaTGFNYQNEDEKVTLcFPSTLQKGSG 98
Cdd:cd09595    3 YDLDLDVDFTTKTLNGTETLTVDASQVGRELVLDLVGLTIHSVSVNGAAVD----FGEREHYDGEKLTI-PGPKPPGQTF 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  99 SLKIDFVGELNDKMKGFYRSKYSssGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNVVDRKP 178
Cdd:cd09595   78 TVRISFEAKPSKNLLGWLWEQTA--GKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGALVGEET 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 179 YAEDqsLVEVKFATTPIMSTYLVAFVIG--EYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVPYP 256
Cdd:cd09595  156 GANG--RKTYRFEDTPPIPTYLVAVVVGdlEFKYVTVKSQPRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGPYP 233
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 257 LPKIDLIAIADFAAGAMENWGLVTYRETALLIDpKNSCASSRQwVALVVGHELAHQWFGNLVTMEWWTHLWLNEGFASWI 336
Cdd:cd09595  234 LPKYDLLAVPDFNSGAMENPGLITFRTTYLLRS-KVTDTGARS-IENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAVYY 311
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 337 EYLCVDHCFPEyDIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDEDFRKGM 416
Cdd:cd09595  312 ENRIMDATFGT-SSRHLDQLSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDKGV 390
                        410       420
                 ....*....|....*....|...
gi 255683531 417 NAYLLKFQHKNASTEDLWECLEQ 439
Cdd:cd09595  391 QAYFNRHKFKNATTDDFIDALEE 413
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
92-490 9.46e-81

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 277.83  E-value: 9.46e-81
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   92 TLQKGSGSLKIDFVGELNDKMKGFYRSKYSSSGEVrYAaVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNM 171
Cdd:TIGR02412  84 GLLTGENTLRVEATRAYTNTGEGLHRFVDPVDGEV-YL-YTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNS 161
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  172 nvVDRKPYAEDQSLVEvKFATTPIMSTYLVAFVIGEYDFVEsQSSDGVTVRVYTPVGKAEQ--GKFALEVATKTLPFYKD 249
Cdd:TIGR02412 162 --RETDVTPEPADRRW-EFPETPKLSTYLTAVAAGPYHSVQ-DESRSYPLGIYARRSLAQYldADAIFTITRQGLAFFHR 237
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  250 YFSVPYPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNscASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLN 329
Cdd:TIGR02412 238 KFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEAT--RAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLN 315
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  330 EGFASWIEYLCVDHCfPEY-DIWTQFVSADYTRALDLDALDNSHPIEVDVGHPSEVDEIFDAISYSKGASVIRMLHNYIG 408
Cdd:TIGR02412 316 ESFAEYMGTLASAEA-TEYtDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVG 394
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  409 DEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSWTKQMGFPIIVVDQEqhgsdrvlkISQKKFCASGPRN 488
Cdd:TIGR02412 395 EEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLTPEIT---------TDGGVVSALYPES 465

                  ..
gi 255683531  489 DE 490
Cdd:TIGR02412 466 SG 467
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
13-452 6.79e-80

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 264.06  E-value: 6.79e-80
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  13 DVypVNYGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFvpDGgeeINATGFNYqnEDEKVTLCFPST 92
Cdd:cd09603    2 DV--LHYDLDLDYDPATKSLSGTATITFRATQDLDSLQLDLVGLTVSSVTV--DG---VPAAFFTH--DGDKLVITLPRP 72
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  93 LQKG-SGSLKIDFVGelNDKMKGFYRSKYSSSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNM 171
Cdd:cd09603   73 LAAGeTFTVTVRYSG--KPRPAGYPPGDGGGWEEGDDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNG 150
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 172 NVVDRKPyaEDQSLVEVKFATTPIMSTYLVAFVIGEYDFVESQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYF 251
Cdd:cd09603  151 RLVSTTT--NGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEELF 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 252 sVPYPLPKIDLIAIADFAaGAMENWGLVTYRETALLIDPKnscassrqWVALVVgHELAHQWFGNLVTMEWWTHLWLNEG 331
Cdd:cd09603  229 -GPYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRG--------SERLIA-HELAHQWFGDSVTCADWADIWLNEG 297
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 332 FASWIEYLCVDHCFPEYDiwtqfvsADYTRALDLDALDNSHPIevdVGHPSEVDEIFDAISYSKGASVIRMLHNYIGDED 411
Cdd:cd09603  298 FATYAEWLWSEHKGGADA-------YRAYLAGQRQDYLNADPG---PGRPPDPDDLFDRDVYQKGALVLHMLRNLLGDEA 367
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|.
gi 255683531 412 FRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSW 452
Cdd:cd09603  368 FFAALRAYLARYAHGNVTTEDFIAAAEEVSGRDLTWFFDQW 408
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
16-200 2.83e-72

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 235.32  E-value: 2.83e-72
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   16 PVNYGLRLKPDLVDFTFEGKLEAAVEVTQGTNQIVMNCADIDIITASFVPDGG-EEINATGFNYQNEDEKVTLCFPSTL- 93
Cdd:pfam17900   2 PEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTsDGVPADFTEDQKDGEKLTIVLPETLn 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   94 QKGSGSLKIDFVGELNDKMKGFYRSKYSSSGEVRYAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALSNMNV 173
Cdd:pfam17900  82 QTGPYTLEIEYSGELNDSMTGFYRSTYTDNGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSNMPV 161
                         170       180
                  ....*....|....*....|....*..
gi 255683531  174 VDRKPYaeDQSLVEVKFATTPIMSTYL 200
Cdd:pfam17900 162 IASEPL--ENGWVITTFEQTPKMSTYL 186
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
109-442 6.97e-41

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 156.14  E-value: 6.97e-41
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 109 NDKMKGFYRSkysssGEVryaAVTQFEATDARRA--FPcwDEPAIKATFDITLIVPKDR--VALSNMNVVDRKPYAEDQs 184
Cdd:cd09600   96 NTSLEGLYKS-----GGI---LCTQCEAEGFRRItyFP--DRPDVMSKFTVTIEADKEKypVLLSNGNLIEEGELPNGR- 164
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 185 lvevKFAT------TPimsTYLVAFVIGEYDFVESQ----SSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVP 254
Cdd:cd09600  165 ----HFAVwedpfpKP---SYLFALVAGDLGSVEDTfttkSGRKVKLRIYVEPGNEDKCHHAMESLKKAMKWDEERFGLE 237
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 255 YPLPKIDLIAIADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGfas 334
Cdd:cd09600  238 YDLDLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEG--- 314
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 335 wieyLCV--DHCFPE----------YDI----WTQFVSadytraldlDALDNSHPIEVDvgHPSEVDEIFDAISYSKGAS 398
Cdd:cd09600  315 ----LTVfrDQEFSAdmnsravkriEDVrrlrSAQFPE---------DAGPMAHPIRPD--SYIEINNFYTVTVYEKGAE 379
                        330       340       350       360
                 ....*....|....*....|....*....|....*....|....
gi 255683531 399 VIRMLHNYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASG 442
Cdd:cd09600  380 VIRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASG 423
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
153-452 1.68e-38

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 149.35  E-value: 1.68e-38
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 153 ATFDITLIVPKD-RVALSnmnvvdrkpyAEDQSLVEVKFATTpimsTYLV--------AFVIGeYDF-VESQSSDGVTVR 222
Cdd:cd09604  161 GDYDVTITVPKNyVVAAT----------GELQNPEEVLDGTK----TWHFkaenvrdfAWAAS-PDFvVDAATVDGVTVN 225
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 223 VYTPVGKAEQGKFALEVATKTLPFYKDYFsVPYPLPKIDLIAiADFAAGAMENWGLVTyretallIDPKNScaSSRQWVA 302
Cdd:cd09604  226 VYYLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGMEYPGLVF-------IGSRLY--DPKRSLE 294
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 303 LVVGHELAHQWF----GNLVTMEwwthLWLNEGFASWIEYLCVDHCFPEYDIWTQFVSADYTRALDLDALDNSHPIEVdv 378
Cdd:cd09604  295 GVVVHEIAHQWFygivGNDERRE----PWLDEGLATYAESLYLEEKYGKEAADELLGRRYYRAYARGPGGPINLPLDT-- 368
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 255683531 379 gHPSEVDEifDAISYSKGASVIRMLHNYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNSW 452
Cdd:cd09604  369 -FPDGSYY--SNAVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVSGKDLDWFFRGW 439
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
11-459 3.22e-27

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 117.57  E-value: 3.22e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   11 PTDVYPVNYGLRLKPDLVDFTFEGKLEAAVEV-TQGTNQIVMNCADIDIITASfvpdggeeINATGFNYQNEDEK----- 84
Cdd:TIGR02411   8 YKDFRTSHTDLNLSVDFTKRKLSGSVTFTLKSlTDNLNKLVLDTSYLDIQKVT--------INGLPADFAIGERKeplgs 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531   85 -VTLCFPSTLQKG-SGSLKIDFvgELNDKMKG--FYRSKYSSSGEVRYAaVTQFEATDARRAFPCWDEPAIKATFDITLI 160
Cdd:TIGR02411  80 pLTISLPIATSKNdEFVLNISF--STTPKCTAlqWLNPEQTSGKKHPYL-FSQCQAIHARSLFPCQDTPSVKSTYTAEVE 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  161 VPkdRVALSNMNVVDRKPYAEDQSLVEVKfatTPIMStYLVAFVIGeyDFVESQSsdGVTVRVYTPVGKAEQGKFALEVA 240
Cdd:TIGR02411 157 SP--LPVLMSGIRDGETSNDPGKYLFKQK---VPIPA-YLIAIASG--DLASAPI--GPRSTVYSEPEQLEKCQYEFEND 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  241 TKTLPFYKDYFSVPYPLPKIDLIAIAD-FAAGAMENWGLvTYRETALLidpknscASSRQWVAlVVGHELAHQWFGNLVT 319
Cdd:TIGR02411 227 TEKFIKTAEDLIFPYEWGQYDLLVLPPsFPYGGMENPNL-TFATPTLI-------AGDRSNVD-VIAHELAHSWSGNLVT 297
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531  320 MEWWTHLWLNEGFASWIEYLCVDHCF--PEYDI-----WTQFVSAdytraldLDALDNSHPIE---VDVgHPSEVDEIFD 389
Cdd:TIGR02411 298 NCSWEHFWLNEGWTVYLERRIIGRLYgeKTRHFsaligWGDLQES-------VKTLGETPEFTklvVDL-KDNDPDDAFS 369
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 255683531  390 AISYSKGASVIRMLHNYIGD-EDFRKGMNAYLLKFQHKNASTEDLWECL-EQASGKPIAAVMNS-----WTKQMGFP 459
Cdd:TIGR02411 370 SVPYEKGFNFLFYLEQLLGGpAEFDPFLRHYFKKFAYKSLDTYQFKDALyEYFKDKKKVDKLDAvdwetWLYSPGMP 446
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
132-438 4.81e-27

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 115.25  E-value: 4.81e-27
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 132 TQFEATDARRAFPCWDEPAIKATFDITLIVPKDRVALsnMNVVdRKPYAEDQSLVEVKFA-TTPIMStYLVAFVIGeyDF 210
Cdd:cd09599  129 TQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTAL--MSAL-RTGEKEEAGTGTYTFEqPVPIPS-YLIAIAVG--DL 202
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 211 VESQSSDgvTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSvPYPLPKID-LIAIADFAAGAMENWGLVTYreTALLId 289
Cdd:cd09599  203 ESREIGP--RSGVWAEPSVVDAAAEEFADTEKFLKAAEKLYG-PYVWGRYDlLVLPPSFPYGGMENPCLTFA--TPTLI- 276
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 290 pknscASSRQWVALVVgHELAHQWFGNLVTMEWWTHLWLNEGFASWIEYLCVDHCF-PEYdiwTQFVSADYTRAL--DLD 366
Cdd:cd09599  277 -----AGDRSLVDVIA-HEIAHSWSGNLVTNANWEHFWLNEGFTVYLERRILERLYgEEY---RQFEAILGWKDLqeSIK 347
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 255683531 367 ALDNSHP-----IEVDVGHPsevDEIFDAISYSKGASVIRMLHNYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLE 438
Cdd:cd09599  348 EFGEDPPytllvPDLKGVDP---DDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLL 421
pepN PRK14015
aminopeptidase N; Provisional
120-529 1.63e-22

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 103.67  E-value: 1.63e-22
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 120 YSSSGevryAAVTQFEATDARRAFPCWDEPAIKATFDITLIVPKDR--VALSNMNVVDRKPYAEDQslvevKFAT----T 193
Cdd:PRK14015 115 YRSGG----MFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKypVLLSNGNLVESGELPDGR-----HWATwedpF 185
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 194 PIMStYLVAFVIGEYDFVE----SQSSDGVTVRVYTPVGKAEQGKFALEVATKTLPFYKDYFSVPYplpkiDL-----IA 264
Cdd:PRK14015 186 PKPS-YLFALVAGDLDVLEdtftTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY-----DLdifmiVA 259
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 265 IADFAAGAMENWGLVTYRETALLIDPKNSCASSRQWVALVVGHELAHQWFGNLVTMEWWTHLWLNEGfaswieyLCV--D 342
Cdd:PRK14015 260 VDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEG-------LTVfrD 332
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 343 HCFpeydiwtqfvSADYT-RAL----DLDALDN----------SHPIEvdvghPSEVDEI---FDAISYSKGASVIRMLH 404
Cdd:PRK14015 333 QEF----------SADLGsRAVkrieDVRVLRAaqfaedagpmAHPVR-----PDSYIEInnfYTATVYEKGAEVIRMLH 397
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 405 NYIGDEDFRKGMNAYLLKFQHKNASTEDLWECLEQASGKPIAAVMNsWTKQMGFPIIVVDQEQHGSDRVLKISQKKFCAS 484
Cdd:PRK14015 398 TLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFRR-WYSQAGTPRVTVSDEYDAAAGTYTLTLSQSTPP 476
                        410       420       430       440       450
                 ....*....|....*....|....*....|....*....|....*....|....*
gi 255683531 485 GPRNDEDCPnWMVPISI----------CTSEDPSCTKTKILLDQPETTVNITNVA 529
Cdd:PRK14015 477 TPGQPEKQP-LHIPVAIglldpdgkelPLQLEGEPVERVLELTEAEQTFTFENVA 530
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
143-417 5.49e-11

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 66.10  E-value: 5.49e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 143 FPCWDEPAIKATFDITLIVPK-----------------------DRVALSNMNVV------DRKPYAEDQSLVEVKFATT 193
Cdd:cd09839  180 FPCVDSLWERCTWELEITVPRtlgdagrpplagskededdddltEEDKELEMVVVcsgdlvEQVVHPEDPSKKTFSFSLS 259
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 194 PIMSTYLVAFVIG-----------EYDFVESQSSDGVTVRVYTPVGKAEqgkfalEVATKTLPFYK--DYFSV---PYPL 257
Cdd:cd09839  260 NPTSAQHIGFAVGpfeivplpefrESEEDDKLGSSAVEVTGFCLPGRLE------ELRNTCSFLHKamDFFEEeygSYPF 333
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 258 P--KI----DLIA-IADFAAGAMENwglvtyreTALL-----IDPknsCASSRQwvALVvgHELAHQWFGNLVTMEWWTH 325
Cdd:cd09839  334 SsyKQvfvdDLPEdVSSFASLSICS--------SRLLyppdiIDQ---AYETRR--KLA--HALASQWFGINIIPKTWSD 398
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 326 LWLNEGFASWIEYLCVDHCF--PEYDIWTQfvsadytraLDLDALdnshpIEVDVGHPS-EVDEIFDAISYS-------K 395
Cdd:cd09839  399 TWLVIGIAGYMTGLFLKKLFgnNEYRFRIK---------KDADRV-----CELDIGRPPlAQPGFILPLDPSelefmalK 464
                        330       340
                 ....*....|....*....|..
gi 255683531 396 GASVIRMLHNYIGDEDFRKGMN 417
Cdd:cd09839  465 APLVLFILDRRLTKTGGSFGLS 486
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
238-339 2.85e-07

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 49.40  E-value: 2.85e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 255683531 238 EVATKTLPFYKDYFSVPYPLPKIDLI--------AIADFAAGAMENWGLVTY------RETALLIDpknscassrqwval 303
Cdd:cd09594    2 SYAHETYKYYEELLGRTSFRYPVSPIysllvypaYVEVNAYNAMWIPSTNIFygagilDTLSGTID-------------- 67
                         90       100       110
                 ....*....|....*....|....*....|....*..
gi 255683531 304 VVGHELAHQWFGNLVTMEW-WTHLWLNEGFASWIEYL 339
Cdd:cd09594   68 VLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGL 104
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH